Veranstaltungsart: Seminar
- Standort:
- Reed Smith's Washington, D.C. Office, 1301 K Street, N.W. Suite 1000, East Tower, Washington D.C. 20005
- Startdatum / -uhrzeit:
- 23 February 2016, 8:30 AM ET
- Enddatum / -uhrzeit:
- 23 February 2016, 4:00 AM ET
On Tuesday, January 26th, Reed Smith’s Washington, D.C. office will host the Food & Drug Law Institute’s “Drug Quality and Security in 2016 Conference.” This program will help drug manufacturers navigate the new and ongoing requirements and regulations resulting from the 2013 Drug Quality and Security Act, and will include comments from key regulators, including Jane Axelrad, JD, Associate Director for Policy, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) and Ilisa Bernstein, PharmD, JD, Deputy Director, Office of Compliance, CDER, FDA.
Date / Time:
26 January 2016 / 8:30 a.m. - 4:00 p.m.